INTI SEC Comment Letters | Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc. SEC Comment Letters

No SEC Comment Letters for INTI on this site yet.

Source checked: its SEC EDGAR filings (CIK 1042418).